EGFR and neoplasm: Together, the data in Figures 2 and 3A strongly suggest that only a small fraction of EGFRs are endocytosed under steady-state growth conditions of HSC3/EGFR-GFP tumor xenografts (in the presence of endogenous EGFR ligands).